Clear all search history
Law & Crime
Disasters & Accidents
War & Conflict
Hospitality & Recreation
Rituxan articles over last 30 days
articles last 30 days
articles per day
Mentioned in this news
Venerable '60 Minutes' Stumbles On How Health Ins...
Contrary to the implication by 60 Minutes, MD Anderson didn’t invent the cancer treatment drug
‒ or it’s method or manner of delivery. MD Anderson isn’t uniquely qualified to diagnose...
Read more at Forbes
The Daily Show
What '60 Minutes' Didn't Say: Hospitals Will Char...
... $15,000 for blood tests costing a few hundred dollars. They charged him $13,702 for a dose of
, a lymphoma drug, for which the average U.S. hospital price is around $4,000. All told,...
Read more at
+ -1 more articles
FDA panel expected to take step toward approving ...
... are frequently used to treat complex diseases such as cancer. Popular biologic drugs include
and Avastin for cancer and Humira for autoimmune disease. A small overseas market already...
Read more at Washington Post
Conkwest Appoints Robert Rosen and Henry Ji to it...
... FcgammaR3 (CD16) and ER-IL2 to efficiently target therapeutic monoclonal antibodies such as
, Herceptin and Erbitux is advancing through the preclinical stage of development. Conkwest...
Read more at Business Wire
Latest from Twitter
Parts of this website powered by Open Calais, a toolkit for rich semantic metadata extraction.
Interceder is a topic search engine aggregating the latest news on any topic into a single window of information. This page has been automatically generated. To contact Interceder
Your privacy is important. Interceder does not collect and keep any personal information about visitors to the site. Interceder may use third-party advertising companies to serve ads. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements on this website, other websites, and other forms of media about goods and services of interest to you.